Baseline circulating myeloid-derived suppressor cells correlate with neutrophil-to-lymphocyte ratio and overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Por:
Garcia-Sanchez, J, Benet, M, Cordon, L, Piqueras, M, Garde-Noguera, J, de Julian, M, Gonzalez-Castillo, L, Lorente, D, Piera, N, Gomez-Soler, M, Ruiz, V, Carretero, J, Sanchez-Hernandez, A, Juan-Vidal, O and Lahoz, A
Publicada:
1 abr 2021
Resumen:
Filiaciones:
:
Hosp Arnau Vilanova, Dept Med Oncol, Valencia, Spain
Benet, M:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
Cordon, L:
Inst Invest Sanitaria La Fe, Flow Cytometry Unit, Valencia, Spain
Piqueras, M:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
:
Hosp Arnau Vilanova, Dept Med Oncol, Valencia, Spain
:
Hosp Univ Doctor Peset, Dept Med Oncol, Valencia, Spain
Gonzalez-Castillo, L:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
Lorente, D:
Hosp Prov Castellon, Dept Med Oncol, Castellon de La Plana, Spain
:
Hosp Arnau Vilanova, Dept Med Oncol, Valencia, Spain
:
Hosp Arnau Vilanova, Dept Med Oncol, Valencia, Spain
Ruiz, V:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
Carretero, J:
Univ Valencia, Dept Physiol, Valencia, Spain
Sanchez-Hernandez, A:
Hosp Prov Castellon, Dept Med Oncol, Castellon de La Plana, Spain
Juan-Vidal, O:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
Lahoz, A:
Inst Invest Sanitaria La Fe, Biomarkers & Precis Med Unit, Valencia, Spain
|